Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat

Life Sciences

Volumn 59, Issue 22, 1996, Pages 1881-1890

  El Daly, Ezzat S ^a  

^a NONE

Author keywords

ACTH; acute; chronic; CRH; morphine; stadol

Indexed keywords

BUTORPHANOL; BUTORPHANOL TARTRATE; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; MORPHINE; OPIATE RECEPTOR;

ADENOHYPOPHYSIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HORMONE BLOOD LEVEL; HORMONE RELEASE; HYPOTHALAMUS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; RADIOIMMUNOASSAY; RAT; REGULATORY MECHANISM; TISSUE LEVEL;

ADRENAL CORTEX; ADRENOCORTICOTROPIC HORMONE; ANIMALS; BUTORPHANOL; CORTICOTROPIN-RELEASING HORMONE; HYPOTHALAMUS; MALE; MORPHINE; PITUITARY GLAND; RATS;

ANIMALIA;

EID: 0030601672     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(96)00535-8     Document Type: Article

References (44)

1. 1. F.N. BRIGGS and P.L. MUNSON, Endocrinology 57 205-219 (1955).
2. 2. R. GEORGE and N. KOKKA,Tissue Response to Addictive Drugs. D.H. Ford and D.H. Clouet, Spectrum, New York, pp. 527-540 (1976).
3. 3. J.C. BUCKINGHAM, Neuroendocrinology 35 111-116 (1982).
4. 4. J.C. BUCKINGHAM and T.A. COOPER, Neuroendocrinology 38 411-417 (1984).
5. 5. S. SUEMARU, K. HASHIMOTO and Z. OKA, Acta Med. Okayama 39 463-470 (1985).
6. 6. J.C. BUCKINGHAM and T.A. COOPER, Neuroendocrinology 44 36-40 (1986).
7. 7. J.C. BUCKINGHAM and T.A. COOPER, Opioid Modulation of Endocrine Function G. Delitala, M. Motta and M. Serio, Raven Press, New York, pp. 81-87 (1984).
8. 8. V.J. LOTTI, N. KOKKA and R. GEORGE, Neuroendocrinology 4 326-332 (1969).
9. 9. E.S. EL DALY, J.Egypt Soc. Toxicol. 12 11-18 (1994).
10. 10. A. BERTOLINI, R. POGGIOLI and W. FRATTA, Life Sci. 29 294 (1981).
11. 11. C. GIANOULAKIS, J.N. DROUIN, N.G. SEIDAH, H. KALANT and M. CHRETIEN, Eur. J. Pharmacol. 72 313 (1981).
12. 12. V. HOLLT, H.M. EMRICH, M. BERGMAN, N. NEDOPIL, D. DIETERLE, H.J. GURLAND, L. NUSSELT, D.V. ZERSSEN and A. HERZ, Endorphins and Opiate Antagonists in Psychiatric Research. N.S. Shah and A.G. Donland, Plenum Press , New Tork, P. 231 (1982).
13. 13. V. HOLLT, and I. HAARMANN, Neuropeptides 5 481 (1985).
14. 14. M. BRADFORD, Anal. Biochem. 72 248-254 (1976).
15. 15. R. PECHNICK, R. GEORGE and R.E. POLAND, J. Pharmacol. Exp. Ther. 232 163-169 (1985).
16. 16. T.A. HOWLETT and L.H. REES, Ann. Rev. Physiol. 48 527-536 (1986).
17. 17. S. IYENGAR, H.S. KIM and P.L. WOOD, Brain Res. 435 220-226 (1987).
18. 18. S.L. LIGHTMAN and W.S. YOUNG, J. Physiol. 403 511 (1988).
19. 19. V. HOLLT, R. PRZEWLOCKI and A. HERZ, Life Sci. 23 1057-1066 (1978).
20. 20. J.A. MARTINEZ, M.L. VARGAS, T. FUENTE, J.D. RIO-GARCIA and M.V. MILANES, Eur. J. Pharmacol. 182 117-123 (1990).
21. 21. A. GIBSON, M. GINSBURG, M. HALL and S.L. HART, Br. J.Pharmacol. 66 164-166 (1979).
22. 22. J. BORRELL and S. BORRELL, Neurosci. Lett. 4 191-195 (1977).
23. 23. M. V. MILANES, J.D. RIO-GARCIA, T. FUENTE, J.A. MARTINEZ and M.L. VARGAS, Gen. Pharmacol. 21 569-571 (1990).
24. 24. M.L. VARGAS, J.A. MARTINEZ, T. FUENTE, J.D. RIO-GARCIA, and M. V. MILANES, Gen. Pharmacol. 22 223-226 (1991).
25. 25. A. GROSSMAN, R.C. GAILARD, P. MCCARTNEY, L.H. REES and G.M. BESSER, Clin. Endocrinol. 17 279-286 (1982).
26. 26. T. HIROSHIGE, K. FUJIEDA, M. KANEKO and K. HONMA, Ann. N.Y. Acad. Sci. 297 436-454 (1977).
27. 27. E.D. FRENCH, F.E. BLOOM, C. RIVIER, R. GUILLEMIN and J. ROSSIER, Soc. Neurosci. Abstr. 4 408 (1978).
28. 28. B. GILLHAM, U. BECKFORD, R.L. INSALL, A. McL. SKELLY, M.T. JONES, J. Endocr. 90 201-210 (1981).
29. 29. J.C. BUCKINGHAM, Br. J. Pharmacol. 75 27 (1982).
30. 30. E.B. DESOUZA and G.R. VAN LOON, Endocrinology 111 1483-1490 (1982).
31. 31. P.M. PLOTSKY, S. OTTO and M. SAPOLSKY, Endocrinology 119 1126-1130 (1986).
32. 32. J. POLKOWSKA and F. PRZEKOP, Acta Endocrinologica (Copenh.) 118 269-276 (1988).
33. 33. O. NIKODIJEVIC, R.P. MAICKEL, Biochem. Pharmacol. 16 2137-2142 (1967).
34. 34. C. GUAZA, A. TORRELLAS, J.K. BORRELL and S. BORRELL, Pharmacol. Biochem. Behav. 11 57-63 (1979).
35. 35. M. WUSTER, R. SCHULZ and A. HERZ, Brain Res. 189 403 (1980).
36. 36. R.K. McDONALD, F.T. EVANS, V.K. WEISE and R.W. PATRICK, J. Pharmacol. Exp. Ther. 125 241-247 (1959).
37. 37. N. KOKKA, J.F. GARCIA and H.W. ELLIOTT, Brain Res. 39 347-354 (1973).
38. 38. P.L. MUNSON, Narcotic and the Hypothalamus, E. Zimmerman and R. George, Raven Press, New York, pp. 361-372 (1974).
39. 39. M.R. BRANDT, J. KORSHIN, A.P. HANSEN, L. HUNNER, S.N. MADSEN, I. RUGG and H. KEHLET, Acta Anaesthesiol. Scand. 22 400-412 (1978).
40. 40. K.A. ABDEL RAHEEM, N. EL MOSSALLAMY, R. HASSAN, S. OKASHA, M. BADAWI and A. ABDEL KADER, Egypt J. Physiol. Sci. 15 97-106 (1991).
41. 41. F. FACCHINETTI, A. GRASSO, F. PETRAGLIA, D. PARRINI, A. VOLPE and A. GENAZZAN, Acta Endocrinol. 105 149 (1984).
42. 42. R.E. MAINS, B.A. EIPPER and N. LING, Proc. Natl. Acad. Sci. U.S.A. 74 3014 (1977).
43. 43. J.L. KOENING, H.Y. MALTZER and G.A. GUDELSKY, Neuroendocrinology 43 611 (1986).
44. 44. C.J. EVANS, E. ERDELYI and J.D. BARCHAS, Psychopharmacol. Bull. 21 466-471 (1985).